Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 779 results for "Shionogi"

Removing Early Barriers To Drugs For Neglected Diseases
Asian Scientist

DNDi and 4 cos team up to accelerate drug discovery for world'...

Drugs for Neglected Diseases initiative (DNDi) and four pharmaceutical firms, Eisai Co Ltd, Shionogi & Co Ltd, Takeda Pharmaceutical Ltd, and AstraZeneca plc have announced the start of a ground-breaking initiative to accelerate and cut the cost of ... PharmaBiz, 2 months ago
Drug Discovery Booster for neglected diseases Laboratory News, 2 weeks ago
Malay Mail

Nikkei edges up but investors still bewitched by Greece Reuters

* Market wants to wait until Greece's referendum - traders * China market moves focused - traders * Shionogi soars after Credit Suisse's rating hike By Ayai Tomisawa TOKYO, June 30 (Reuters) - Japan's Nikkei share average ...
 Yahoo! Finance1 month ago Nikkei rebounds on buybacks  Japan Times1 month ago Nikkei edges up but Greece uncertainty still looms  Hindu Business Line1 month ago Japan shares fluctuate as investors assess possible Greek fallout  Malay Mail1 month ago
[x]  

SHIONOGI : Findings on Alkylated Estrogenic Steroids Discussed by Investigators at Shionogi & Co. Ltd. (Dolutegravir Has No Effect on the Pharmacokinetics...

Findings on Alkylated Estrogenic Steroids Discussed by Investigators at Shionogi & Co. Ltd. (Dolutegravir Has No Effect on the Pharmacokinetics of Oral Contraceptives With Norgestimate and Ethinyl Estradiol) By a News Reporter-Staff News Editor ...
 4 Traders1 week ago

Shionogi Announces the Continued Expansion of their Operations in Europe with the Launch of Shionogi Italy

 Noodls2 weeks ago

Shionogi to Determine the Contents of Stock Options as Compensation (Stock Acquisition Rights)

 Noodls3 weeks ago Shionogi to Issue of Stock Options as Compensation (Stock Acquisition Rights) to Members of Board of Directors  Noodls1 month ago
IChainnel

GSK's ViiV turns to Chinese company for cheap supply of Tivicay API

The HIV-oriented joint venture of Pfizer ($PFE), GlaxoSmithKline ($GSK) and Japan's Shionogi is turning to a Chinese manufacturer for a cheap supply of dolutegravir, the active ingredient in its Tivicay. The deal is seen as a way to cut the cost in ...
 IChainnel4 weeks ago

Investigation Report on China Rosuvastatin Market, 2010-2019

First developed by Shionogi Inc. under the code name of S-4522 at the end of 1980s, rosuvastatin (rosuvastatin calcium) along with its development, marketing and sales rights, was transferred to AstraZeneca in Jun. 1998 under the code name of ...
 MarketResearch.com1 month ago

SHIONOGI ANNOUNCES THAT NALDEMEDINE MET THE PRIMARY ENDPOINT IN ITS FIRST JAPANESE PHASE 3 STUDY FOR THE TREATMENT OF OPIOID-INDUCED CONSTIPATION IN CANCER PATIENTS

 Noodls1 month ago
Global Information Inc

Thrombocytopenia Pipeline Review, H1 2015 - 35 Companies & 41 Drug Profiles

Research and Markets (http://www.researchandmarkets.com/research/jqnh8b/thrombocytopenia) has announced the addition of the "Thrombocytopenia - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the ...
 Individual.com13 hours ago Research and Markets: Thrombocytopenia Pipeline Review, H1 2015 - 35 Companies & 41 Drug Profiles  BioMedReports12 hours ago Global Opioid-Induced Constipation Market Report 2015-2019 - Shift to Targeted Therapy with AstraZeneca, Takeda Pharmaceutical & Valeant Pharmaceuticals International Dominating  Ulitzer1 week ago Opioid-Induced Constipation Market to Grow at 30% CAGR by 2019 Says a New Research Report at ReportsnReports.com July 10, 2015The Global Opioid-In​duced Constipation Market 2015-2019 report says the shift to targeted therapy is the latest trend observed i  PRWeb6 days ago
[x]  

Finding a Cure for Kala Azar

An unprecedented global initiative is helping to develop and fast-track drugs for diseases mainly affecting the poor. Research and development for new medicines is costly, time-consuming and almost always profit driven. So when a disease ...
 Al Jazeera14 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less